Advertisement
Advertisement
QNRX
Quoin Pharmaceuticals, Ltd. - ADR
6.49
USDSponsored
+0.19
+3.02%
Apr 15, 15:59 UTC -4
Closed
After-Market
6.48
-0.01
-0.15%
QNRX Earnings Reports
Positive Surprise Ratio
QNRX beat 15 of 22 last estimates.
68%
Next Report
Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$1.87
Implied change from Q4 25 (Revenue/ EPS)
--
/+24.67%
Implied change from Q1 25 (Revenue/ EPS)
--
/-71.23%
Quoin Pharmaceuticals, Ltd. - ADR earnings per share and revenue
On Mar 26, 2026, QNRX reported earnings of -1.50 USD per share (EPS) for Q4 25, beating the estimate of -3.40 USD, resulting in a 55.93% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -4.71% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of -1.87 USD, with revenue projected to reach -- USD, implying an increase of 24.67% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Jupiter Neurosciences, Inc. Common Stock
Report Date
Apr 01, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.06
Surprise
+6.16%
BIOMERICA INC
Report Date
Apr 13, 2026 For Q3 26
Estimate
-Actual
-$0.44
Surprise
-
Cardiol Therapeutics Inc. Class A Common Shares
Report Date
Apr 01, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.07
Surprise
+14.22%
FAQ
What were Quoin Pharmaceuticals, Ltd. - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Quoin Pharmaceuticals, Ltd. - ADR reported EPS of -$1.50, beating estimates by 55.93%, and revenue of $0.00, 0% as expectations.
How did the market react to Quoin Pharmaceuticals, Ltd. - ADR's Q4 2025 earnings?
The stock price moved down -4.71%, changed from $8.49 before the earnings release to $8.09 the day after.
When is Quoin Pharmaceuticals, Ltd. - ADR expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Quoin Pharmaceuticals, Ltd. - ADR's next earnings report?
Based on 3
analysts, Quoin Pharmaceuticals, Ltd. - ADR is expected to report EPS of -$1.87 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement